Old Web
English
Sign In
Acemap
>
authorDetail
>
L. Sellers
L. Sellers
Imperial College London
Hepatocellular carcinoma
Sorafenib
Medicine
Cancer
Biomarker (medicine)
3
Papers
34
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
On-target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi-centre, prospective study
2017
Alimentary Pharmacology & Therapeutics
Jessica Howell
David J. Pinato
Ramya Ramaswami
D Bettinger
Tadaaki Arizumi
C. Ferrari
C. Yen
Antonello Gibbin
M.E. Burlone
Giulia Guaschino
L. Sellers
J. Black
M. Pirisi
Masatoshi Kudo
Robert Thimme
J.W. Park
Rohini Sharma
Show All
Source
Cite
Save
Citations (34)
Integration of the cancer-related pro-inflammatory response as a stratifying biomarker of survival benefit with sorafenib in hepatocellular carcinoma
2016
Journal of Gastroenterology and Hepatology
Jessica Howell
David J. Pinato
Ramya Ramaswami
Tadaaki Arizumi
C. Ferrari
Antonello Gibbin
M.E. Burlone
Giulia Guaschino
J. Black
L. Sellers
Masatoshi Kudo
Mario Pirisi
Rohini Sharma
Show All
Source
Cite
Save
Citations (0)
Integration of the Cancer-Related Pro-Inflammatory Response as a Stratifying Biomarker of Survival Benefit with Sorafenib in Hepatocellular Carcinoma
2016
Journal of Hepatology
Jessica Howell
David J. Pinato
Ramya Ramaswami
Tadaaki Arizumi
C. Ferrari
Antonello Gibbin
M.E. Burlone
Giulia Guaschino
J. Black
L. Sellers
Masatoshi Kudo
Mario Pirisi
Rohini Sharma
Show All
Source
Cite
Save
Citations (0)
1